Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephraim J Fuchs

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2013
HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantationAmer M Zeidan, Patrick M Forde, Heather Symons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort StudySuman Paul, Marianna Zahurak, Leo Luznik, et al.
Transplantation and Cellular Therapy|November 9, 2025
TEMPORARY REMOVAL: Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow TransplantationChristian B Gocke, Marianna Zahurak, Ilias Sinanidis, et al.
Blood|June 3, 2004
Association of Foxp3 regulatory gene expression with graft-versus-host diseaseYuji Miura, Christopher J Thoburn, Emilie C Bright, et al.
Blood Advances|December 18, 2024
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphomaNadeem Tabbara, Marianna Zahurak, Cole H Sterling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2019
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic LeukemiaSuman Paul, Hua-Ling Tsai, Patrick Lowery, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Blood|December 19, 2009
High-dose cyclophosphamide for severe aplastic anemia: long-term follow-upRobert A Brodsky, Allen R Chen, Donna Dorr, et al.
Blood Advances|September 8, 2018
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamideLaura K Schoch, Kenneth R Cooke, Nina D Wagner-Johnston, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2013
HLA-haploidentical donor lymphocyte infusions for patients with relapsed hematologic malignancies after related HLA-haploidentical bone marrow transplantationAmer M Zeidan, Patrick M Forde, Heather Symons, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2020
Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort StudySuman Paul, Marianna Zahurak, Leo Luznik, et al.
Transplantation and Cellular Therapy|November 9, 2025
TEMPORARY REMOVAL: Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow TransplantationChristian B Gocke, Marianna Zahurak, Ilias Sinanidis, et al.
Blood|June 3, 2004
Association of Foxp3 regulatory gene expression with graft-versus-host diseaseYuji Miura, Christopher J Thoburn, Emilie C Bright, et al.
Blood Advances|December 18, 2024
Improved overall survival with checkpoint inhibition and allogeneic transplantation in relapsed Hodgkin lymphomaNadeem Tabbara, Marianna Zahurak, Cole H Sterling, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2019
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic LeukemiaSuman Paul, Hua-Ling Tsai, Patrick Lowery, et al.
Pageof 12